| Peter George Mavrelis, MD | |
|
7895 Grand Blvd, Hobart, IN 46342-6665 | |
| (219) 947-1910 | |
| (219) 758-5009 |
| Full Name | Peter George Mavrelis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 7895 Grand Blvd, Hobart, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326043597 | NPI | - | NPPES |
| 000000085027 | Other | IN | ANTHEM BC/BS |
| 100138640A | Medicaid | IN | |
| 9115389 | Other | IL | ANTHEM BC/BS |
| 110044491 | Other | IN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01030831A (Indiana) | Primary |
| Entity Name | Internal Medicine Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487685178 PECOS PAC ID: 9133191604 Enrollment ID: O20040806000539 |
News Archive
The number of people battling acute hunger and suffering from malnutrition is on the rise again. The upheaval set in motion by the COVID-19 pandemic may push even more families and communities into deeper distress.
EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.
Formaldehyde can cause acute health problems and possibly even cancer. With the new portable product, GASERA ONE FORMALDEHYDE, we can monitor the indoor and outdoor background levels reliably for the first time.
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
› Verified 2 days ago
| Entity Name | The Methodist Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720290588 PECOS PAC ID: 9638063894 Enrollment ID: O20080805000003 |
News Archive
The number of people battling acute hunger and suffering from malnutrition is on the rise again. The upheaval set in motion by the COVID-19 pandemic may push even more families and communities into deeper distress.
EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.
Formaldehyde can cause acute health problems and possibly even cancer. With the new portable product, GASERA ONE FORMALDEHYDE, we can monitor the indoor and outdoor background levels reliably for the first time.
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
› Verified 2 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
The number of people battling acute hunger and suffering from malnutrition is on the rise again. The upheaval set in motion by the COVID-19 pandemic may push even more families and communities into deeper distress.
EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.
Formaldehyde can cause acute health problems and possibly even cancer. With the new portable product, GASERA ONE FORMALDEHYDE, we can monitor the indoor and outdoor background levels reliably for the first time.
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter George Mavrelis, MD 7895 Grand Blvd, Hobart, IN 46342-6665 Ph: (219) 947-1910 | Peter George Mavrelis, MD 7895 Grand Blvd, Hobart, IN 46342-6665 Ph: (219) 947-1910 |
News Archive
The number of people battling acute hunger and suffering from malnutrition is on the rise again. The upheaval set in motion by the COVID-19 pandemic may push even more families and communities into deeper distress.
EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.
Formaldehyde can cause acute health problems and possibly even cancer. With the new portable product, GASERA ONE FORMALDEHYDE, we can monitor the indoor and outdoor background levels reliably for the first time.
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
› Verified 2 days ago
Maali Milhem, MBBS Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1354 S Lake Park Ave, Hobart, IN 46342 Phone: 219-945-5888 Fax: 219-945-5880 | |
Javairia Quraishi, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 219-945-4580 Fax: 219-945-4581 | |
Abdul Tamim Ward, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 055-121-9942 | |
Dr. May Y. Lee, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7875 Grand Blvd, Pulmonary Specialists Of Northwest Indiana, Pc, Hobart, IN 46342 Phone: 219-942-9658 Fax: 219-947-1996 | |
Denise C Weaver, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave Ste 304, Hobart, IN 46342 Phone: 219-947-6638 Fax: 219-703-6693 | |
Milton Stanley Gasparis, MD PHD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1352 S Lake Park Ave, Hobart, IN 46342 Phone: 219-942-7244 Fax: 219-942-0975 | |
Bantu Samridhi Chhangani, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 219-942-0551 |